Allergic Conjunctivitis Market Information Related To Pipeline Products, News and Deals is Available In The Report
"The Report Allergic
Conjunctivitis - Pipeline Review, H1 2018 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
About
Allergic
Conjunctivitis
Market
Global Markets Direct's latest
Pharmaceutical and Healthcare disease pipeline guide Allergic
Conjunctivitis - Pipeline Review, H1 2018, provides an overview of
the Allergic Conjunctivitis (Ophthalmology) pipeline landscape.
Get
Sample copy of this Report @
https://www.marketresearchreports.biz/sample/sample/1743253
Allergic conjunctivitis occurs
when the clear layer of tissue lining the eyelids and covering the
white of the eye (conjunctiva) become swollen or inflamed due to a
reaction to pollen, dander, mold, or other allergy-causing
substances. Symptoms include intense itching, puffy eyelids, widened
(dilated) vessels in the clear tissue covering the white of the eye
and stringy eye discharge. Treatment includes antihistamine or
anti-inflammatory medication.
Report Highlights
Global Markets Direct's
Pharmaceutical and Healthcare latest pipeline guide Allergic
Conjunctivitis - Pipeline Review, H1 2018, provides comprehensive
information on the therapeutics under development for Allergic
Conjunctivitis (Ophthalmology), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type.
The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.
The
Allergic Conjunctivitis (Ophthalmology) pipeline guide also reviews
of key players involved in therapeutic development for Allergic
Conjunctivitis and features dormant and discontinued projects. The
guide covers therapeutics under Development by Companies
/Universities /Institutes, the molecules developed by Companies in
Phase III, Phase II, Phase I, Preclinical and Discovery stages are 4,
4, 2, 7 and 1 respectively.
Request
for TOC @
https://www.marketresearchreports.biz/reports/1743253/allergic-conjunctivitis-pipeline-review-h1-2018-market-research-reports/toc
Allergic Conjunctivitis
(Ophthalmology) pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios, enhances
decision making capabilities and helps to create effective counter
strategies to gain competitive advantage.
The guide is built using data and
information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time
basis.
Note: Certain content / sections
in the pipeline guide may be removed or altered based on the
availability and relevance of data.
Scope
- The pipeline guide provides a
snapshot of the global therapeutic landscape of Allergic
Conjunctivitis (Ophthalmology).
- The pipeline guide reviews
pipeline therapeutics for Allergic Conjunctivitis (Ophthalmology) by
companies and universities/research institutes based on information
derived from company and industry-specific sources.
- The pipeline guide covers
pipeline products based on several stages of development ranging from
pre-registration till discovery and undisclosed stages.
- The pipeline guide features
descriptive drug profiles for the pipeline products which comprise,
product description, descriptive licensing and collaboration details,
R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key
companies involved in Allergic Conjunctivitis (Ophthalmology)
therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates
Allergic Conjunctivitis (Ophthalmology) therapeutics based on
mechanism of action (MoA), drug target, route of administration (RoA)
and molecule type.
- The pipeline guide encapsulates
all the dormant and discontinued pipeline projects.
- The pipeline guide reviews
latest news related to pipeline therapeutics for Allergic
Conjunctivitis (Ophthalmology)
Reasons to buy
-
Procure strategically important competitor information, analysis, and
insights to formulate effective R&D strategies.
- Recognize emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage.
- Find and recognize significant
and varied types of therapeutics under development for Allergic
Conjunctivitis (Ophthalmology).
- Classify potential new clients
or partners in the target demographic.
- Develop tactical initiatives by
understanding the focus areas of leading companies.
- Plan mergers and acquisitions
meritoriously by identifying key players and its most promising
pipeline therapeutics.
- Formulate corrective measures
for pipeline projects by understanding Allergic Conjunctivitis
(Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing
and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential
and scope.
- Adjust the therapeutic portfolio
by recognizing discontinued projects and understand from the know-how
what drove them from pipeline.
View
Report @
https://www.marketresearchreports.biz/reports/1743253/allergic-conjunctivitis-pipeline-review-h1-2018-market-research-reports
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report
Coverage
Allergic Conjunctivitis - Overview
Allergic Conjunctivitis -
Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by
Companies
Allergic Conjunctivitis -
Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of
Administration
Assessment by Molecule Type
Allergic Conjunctivitis -
Companies Involved in Therapeutics Development
Accolade Pharmaceuticals LLC
Aldeyra Therapeutics Inc
AlleCures Inc
Allergan Plc
Clevexel Pharma SAS
Griffin Discoveries BV
iCo Therapeutics Inc.
Ocular Therapeutix Inc
Ohr Pharmaceutical Inc
Portola Pharmaceuticals Inc
Re-Pharm Ltd
Sylentis SAU
Xencor Inc
Allergic Conjunctivitis - Drug
Profiles
AGN-229666 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AK-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bertilimumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CPC-888 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CVXL-0074 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dexamethasone SR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Allergic Conjunctivitis
- Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EM-100 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GD-134 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GD-136 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PRT-2761 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
reproxalap - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RP-0217 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
About us
MarketResearchReports.biz is the
most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Comments
Post a Comment